Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $9.3 million.

  • Amylyx Pharmaceuticals' Prepaid Assets rose 135.71% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 135.71%. This contributed to the annual value of $12.5 million for FY2024, which is 1638.87% down from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Prepaid Assets stood at $9.3 million for Q3 2025, which was up 135.71% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Prepaid Assets registered a high of $17.3 million during Q3 2023, and its lowest value of $5.4 million during Q4 2021.
  • In the last 5 years, Amylyx Pharmaceuticals' Prepaid Assets had a median value of $11.0 million in 2022 and averaged $11.2 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 10798.94% in 2023, then tumbled by 5349.87% in 2025.
  • Quarter analysis of 5 years shows Amylyx Pharmaceuticals' Prepaid Assets stood at $5.4 million in 2021, then surged by 87.56% to $10.1 million in 2022, then surged by 47.64% to $14.9 million in 2023, then dropped by 16.39% to $12.5 million in 2024, then fell by 25.82% to $9.3 million in 2025.
  • Its Prepaid Assets was $9.3 million in Q3 2025, compared to $6.0 million in Q2 2025 and $11.8 million in Q1 2025.